294 related articles for article (PubMed ID: 30253780)
21. Analysis of monocyte infiltration in MPTP mice reveals that microglial CX3CR1 protects against neurotoxic over-induction of monocyte-attracting CCL2 by astrocytes.
Parillaud VR; Lornet G; Monnet Y; Privat AL; Haddad AT; Brochard V; Bekaert A; de Chanville CB; Hirsch EC; Combadière C; Hunot S; Lobsiger CS
J Neuroinflammation; 2017 Mar; 14(1):60. PubMed ID: 28320442
[TBL] [Abstract][Full Text] [Related]
22. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
23. Chronic neuroinflammation and cognitive impairment following transient global cerebral ischemia: role of fractalkine/CX3CR1 signaling.
Briones TL; Woods J; Wadowska M
J Neuroinflammation; 2014 Jan; 11():13. PubMed ID: 24447880
[TBL] [Abstract][Full Text] [Related]
24. Microglial CX3CR1 promotes adult neurogenesis by inhibiting Sirt 1/p65 signaling independent of CX3CL1.
Sellner S; Paricio-Montesinos R; Spieß A; Masuch A; Erny D; Harsan LA; Elverfeldt DV; Schwabenland M; Biber K; Staszewski O; Lira S; Jung S; Prinz M; Blank T
Acta Neuropathol Commun; 2016 Sep; 4(1):102. PubMed ID: 27639555
[TBL] [Abstract][Full Text] [Related]
25. Loss of tau rescues inflammation-mediated neurodegeneration.
Maphis N; Xu G; Kokiko-Cochran ON; Cardona AE; Ransohoff RM; Lamb BT; Bhaskar K
Front Neurosci; 2015; 9():196. PubMed ID: 26089772
[TBL] [Abstract][Full Text] [Related]
26. Repopulating retinal microglia restore endogenous organization and function under CX3CL1-CX3CR1 regulation.
Zhang Y; Zhao L; Wang X; Ma W; Lazere A; Qian HH; Zhang J; Abu-Asab M; Fariss RN; Roger JE; Wong WT
Sci Adv; 2018 Mar; 4(3):eaap8492. PubMed ID: 29750189
[TBL] [Abstract][Full Text] [Related]
27. Maternal Immune Activation Sensitizes Male Offspring Rats to Lipopolysaccharide-Induced Microglial Deficits Involving the Dysfunction of CD200-CD200R and CX3CL1-CX3CR1 Systems.
Chamera K; Szuster-Głuszczak M; Trojan E; Basta-Kaim A
Cells; 2020 Jul; 9(7):. PubMed ID: 32664639
[TBL] [Abstract][Full Text] [Related]
28. Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology.
Maphis N; Jiang S; Xu G; Kokiko-Cochran ON; Roy SM; Van Eldik LJ; Watterson DM; Lamb BT; Bhaskar K
Alzheimers Res Ther; 2016 Dec; 8(1):54. PubMed ID: 27974048
[TBL] [Abstract][Full Text] [Related]
29. Phos-tau peptide immunization of amyloid-tg-mice reduced non-mutant phos-tau pathology, improved cognition and reduced amyloid plaques.
Benhamron S; Rozenstein-Tsalkovich L; Nitzan K; Abramsky O; Rosenmann H
Exp Neurol; 2018 May; 303():48-58. PubMed ID: 29432723
[TBL] [Abstract][Full Text] [Related]
30. Microglial phagocytosis and activation underlying photoreceptor degeneration is regulated by CX3CL1-CX3CR1 signaling in a mouse model of retinitis pigmentosa.
Zabel MK; Zhao L; Zhang Y; Gonzalez SR; Ma W; Wang X; Fariss RN; Wong WT
Glia; 2016 Sep; 64(9):1479-91. PubMed ID: 27314452
[TBL] [Abstract][Full Text] [Related]
31. Microglial Cx3cr1 knockout reduces prion disease incubation time in mice.
Grizenkova J; Akhtar S; Brandner S; Collinge J; Lloyd SE
BMC Neurosci; 2014 Mar; 15():44. PubMed ID: 24655482
[TBL] [Abstract][Full Text] [Related]
32. Microglial activation in brain lesions with tau deposits: comparison of human tauopathies and tau transgenic mice TgTauP301L.
Sasaki A; Kawarabayashi T; Murakami T; Matsubara E; Ikeda M; Hagiwara H; Westaway D; George-Hyslop PS; Shoji M; Nakazato Y
Brain Res; 2008 Jun; 1214():159-68. PubMed ID: 18457819
[TBL] [Abstract][Full Text] [Related]
33. Traumatic Brain Injury in hTau Model Mice: Enhanced Acute Macrophage Response and Altered Long-Term Recovery.
Kokiko-Cochran ON; Saber M; Puntambekar S; Bemiller SM; Katsumoto A; Lee YS; Bhaskar K; Ransohoff RM; Lamb BT
J Neurotrauma; 2018 Jan; 35(1):73-84. PubMed ID: 28859549
[TBL] [Abstract][Full Text] [Related]
34. Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy.
Javidnia M; Hebron ML; Xin Y; Kinney NG; Moussa CE
J Alzheimers Dis; 2017; 60(2):461-481. PubMed ID: 28869476
[TBL] [Abstract][Full Text] [Related]
35. Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology.
Polydoro M; Acker CM; Duff K; Castillo PE; Davies P
J Neurosci; 2009 Aug; 29(34):10741-9. PubMed ID: 19710325
[TBL] [Abstract][Full Text] [Related]
36. Involvement of CX3CL1/CX3CR1 in depression and cognitive impairment induced by chronic unpredictable stress and relevant underlying mechanism.
Liu Y; Zhang T; Meng D; Sun L; Yang G; He Y; Zhang C
Behav Brain Res; 2020 Mar; 381():112371. PubMed ID: 31765724
[TBL] [Abstract][Full Text] [Related]
37. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.
Chalermpalanupap T; Schroeder JP; Rorabaugh JM; Liles LC; Lah JJ; Levey AI; Weinshenker D
J Neurosci; 2018 Jan; 38(1):74-92. PubMed ID: 29133432
[TBL] [Abstract][Full Text] [Related]
38. Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model.
van Olst L; Verhaege D; Franssen M; Kamermans A; Roucourt B; Carmans S; Ytebrouck E; van der Pol SMA; Wever D; Popovic M; Vandenbroucke RE; Sobrino T; Schouten M; de Vries HE
Neurobiol Aging; 2020 May; 89():89-98. PubMed ID: 32008854
[TBL] [Abstract][Full Text] [Related]
39. Fractalkine receptor (CX3CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharide.
Corona AW; Huang Y; O'Connor JC; Dantzer R; Kelley KW; Popovich PG; Godbout JP
J Neuroinflammation; 2010 Dec; 7():93. PubMed ID: 21167054
[TBL] [Abstract][Full Text] [Related]
40. Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis.
Lastres-Becker I; Innamorato NG; Jaworski T; Rábano A; Kügler S; Van Leuven F; Cuadrado A
Brain; 2014 Jan; 137(Pt 1):78-91. PubMed ID: 24277722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
